Molecular and biochemical basis of intermediate maple syrup urine disease. Occurrence of homozygous G245R and F364C mutations at the E1 alpha locus of Hispanic-Mexican patients
- PMID: 7883996
- PMCID: PMC441427
- DOI: 10.1172/JCI117804
Molecular and biochemical basis of intermediate maple syrup urine disease. Occurrence of homozygous G245R and F364C mutations at the E1 alpha locus of Hispanic-Mexican patients
Abstract
Maple syrup urine disease (MSUD) is caused by a deficiency of the mitochondrial branched-chain alpha-keta acid dehydrogenase (BCKAD) complex. The multienzyme complex comprises five enzyme components, including the E1 decarboxylase with a heterotetrameric (alpha 2 beta 2) structure. Four unrelated Hispanic-Mexican MSUD patients with the intermediate clinical phenotype were diagnosed 7 to 22 mo after birth during evaluation for developmental delay. Three of the four patients were found homozygous for G to A transition at base 895 (exon 7) of the E1 alpha locus, which changes Gly-245 to Arg (G245R) in that subunit. The remaining patient was homozygous for T to G transversion at base 1,253 in the E1 alpha gene, which converts Phe-364 to Cys (F364C) in the gene product. Transfection studies in E1 alpha-deficient lymphoblasts indicate that both G245R and F364C mutant E1 alpha subunits were unable to significantly reconstitute BCKAD activity. Western blotting showed that both mutant E1 alpha subunits in transfected cells failed to efficiently rescue the normal E1 beta through assembly. The putative assembly defect was confirmed by pulse-chase labeling of E1 subunits in a chaperone-augmented bacterial overexpression system. The kinetics of initial assembly of the G245R E1 alpha subunit with the normal E1 beta was shown to be slower than the normal E1 alpha. No detectable assembly of the F364C E1 alpha with normal E1 beta was observed during the 2 h chase. Small amounts of recombinant mutant E1 proteins were produced after 15 h induction with isopropyl thiogalactoside and exhibited very low or no E1 activity. Our study establishes that G245R and F364C mutations in the E1 alpha subunit disrupt both the E1 heterotetrameric assembly and function of the BCKAD complex. Moreover, the results suggest that the G245R mutant E1 alpha allele may be important in the Hispanic-Mexican population.
Similar articles
-
Maple syrup urine disease: domain structure, mutations and exon skipping in the dihydrolipoyl transacylase (E2) component of the branched-chain alpha-keto acid dehydrogenase complex.Mol Biol Med. 1991 Feb;8(1):49-63. Mol Biol Med. 1991. PMID: 1943690
-
Maple syrup urine disease. Complete defect of the E1 beta subunit of the branched chain alpha-ketoacid dehydrogenase complex due to a deletion of an 11-bp repeat sequence which encodes a mitochondrial targeting leader peptide in a family with the disease.J Clin Invest. 1991 May;87(5):1862-6. doi: 10.1172/JCI115209. J Clin Invest. 1991. PMID: 2022752 Free PMC article.
-
Molecular basis of intermittent maple syrup urine disease: novel mutations in the E2 gene of the branched-chain alpha-keto acid dehydrogenase complex.J Hum Genet. 1998;43(2):91-100. doi: 10.1007/s100380050047. J Hum Genet. 1998. PMID: 9621512
-
[Gene analysis of maple syrup urine disease (MSUD)].Rinsho Byori. 1993 May;41(5):484-91. Rinsho Byori. 1993. PMID: 8350511 Review. Japanese.
-
Molecular basis of maple syrup urine disease and stable correction by retroviral gene transfer.J Nutr. 1995 Jun;125(6 Suppl):1766S-1772S. doi: 10.1093/jn/125.suppl_6.1766S. J Nutr. 1995. PMID: 7782943 Review.
Cited by
-
Maple syrup urine disease: the E1beta gene of human branched-chain alpha-ketoacid dehydrogenase complex has 11 rather than 10 exons, and the 3' UTR in one of the two E1beta mRNAs arises from intronic sequences.Am J Hum Genet. 1996 Jun;58(6):1373-7. Am J Hum Genet. 1996. PMID: 8651316 Free PMC article. No abstract available.
-
The role of protein complexes in human genetic disease.Protein Sci. 2019 Aug;28(8):1400-1411. doi: 10.1002/pro.3667. Epub 2019 Jul 1. Protein Sci. 2019. PMID: 31219644 Free PMC article. Review.
-
E2 transacylase-deficient (type II) maple syrup urine disease. Aberrant splicing of E2 mRNA caused by internal intronic deletions and association with thiamine-responsive phenotype.J Clin Invest. 1997 Aug 1;100(3):736-44. doi: 10.1172/JCI119586. J Clin Invest. 1997. PMID: 9239422 Free PMC article.
-
Phenylbutyrate therapy for maple syrup urine disease.Hum Mol Genet. 2011 Feb 15;20(4):631-40. doi: 10.1093/hmg/ddq507. Epub 2010 Nov 23. Hum Mol Genet. 2011. PMID: 21098507 Free PMC article. Clinical Trial.
-
Maple syrup urine disease in Cypriot families: identification of three novel mutations and biochemical characterization of the p.Thr211Met mutation in the E1alpha subunit.Genet Test Mol Biomarkers. 2009 Oct;13(5):657-64. doi: 10.1089/gtmb.2009.0065. Genet Test Mol Biomarkers. 2009. PMID: 19715473 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials